Empowering the Voice of Kansas Pharmacy

Log in

Latest News

Pharmacy News & Notes

Share your news with KPhA! Submit an announcement.

  • 03/30/2020 2:39 PM | Anonymous member (Administrator)

    The Drug Enforcement Administration (DEA) has provided the following guidance regarding the issuance of oral schedule II prescriptions in light of the nationwide public health emergency declared by the Secretary of Health and Human Services on Jan. 31.

    First, the DEA has expanded the time frame - from seven to 15 days - for which a prescriber has to provide a written prescription to the pharmacy. Second, it notes the follow-up written prescription may be sent to the pharmacy via facsimile, or a photographed/scanned copy may be sent to the pharmacy.

    These exceptions shall remain in place for the duration of the Public Health Emergency (unless modified or withdrawn by DEA).

    Read more.

  • 03/30/2020 2:18 PM | Anonymous member (Administrator)

    KPhA wants to make sure you receive information related to COVID-19 and the Federal and State responses to the pandemic as quickly as possible.

    One item that was just clarified last night was whether or not pharmacy staff were going to be exempted as "healthcare providers" under the Families First Coronavirus Response Act. The US Department of Labor released their official guidance last night that included the following:

    #56 Who is a “health care provider” who may be excluded by their employer from paid sick leave and/or expanded family and medical leave?

    1.    For the purposes of employees who may be exempted from paid sick leave or expanded family and medical leave by their employer under the FFCRA, a health care provider is anyone employed at any doctor’s office, hospital, health care center, clinic, post-secondary educational institution offering health care instruction, medical school, local health department or agency, nursing facility, retirement facility, nursing home, home health care provider, any facility that performs laboratory or medical testing, pharmacy, or any similar institution, employer, or entity. This includes any permanent or temporary institution, facility, location, or site where medical services are provided that are similar to such institutions.

    This definition includes any individual employed by an entity that contracts with any of the above institutions, employers, or entities institutions to provide services or to maintain the operation of the facility. This also includes anyone employed by any entity that provides medical services, produces medical products, or is otherwise involved in the making of COVID-19 related medical equipment, tests, drugs, vaccines, diagnostic vehicles, or treatments. This also includes any individual that the highest official of a state or territory, including the District of Columbia, determines is a health care provider necessary for that state’s or territory’s or the District of Columbia’s response to COVID-19.

    To minimize the spread of the virus associated with COVID-19, the Department encourages employers to be judicious when using this definition to exempt health care providers from the provisions of the FFCRA.

    Please let us know if you have any questions regarding this guidance, and we will do our best to get you an answer.

  • 03/30/2020 1:00 PM | Anonymous member (Administrator)

    Pharmacies are being inundated with companies promoting potentially fraudulent materials related to COVID-19 testing, including marketing FDA certification. The FDA is still in the process of reviewing many of these authorizations and have shared with us a few key points to help discern whether a company is legitimate.

    The FDA list of all current authorized tests, updated daily.

    These FDA pages addresses available diagnostic and therapeutic medical devices to diagnosis and respond to COVID-19:

    • Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices
    • Personal Protective Equipment EUA
    • In Vitro Diagnostic EUAs

    As of today, (March 29, 2020):

    • There is no “Home Test” authorized for SARS-CoV-2 (COVID-19).
    • There are emergency use authorized (EUA) point of care (POC) tests, but these tests are not CLIA waived.

    View a list of Laboratories and Manufacturers that are Offering Tests for COVID-19.

    Any additional diagnostic questions should be submitted to: COVID19DX@fda.hhs.gov

    As a reminder, any concerns regarding fraudulent products, including tests, should be sent to: FDA-COVID-19-Fraudulent-Products@fda.hhs.gov

  • 03/26/2020 10:59 PM | Anonymous member (Administrator)

    Physicians’ and pharmacists’ first and foremost ethical obligation in situations of epidemic, disaster or terrorism is to provide urgent medical care and ensure availability and appropriate use of necessary medications. This requires close coordination with the entire healthcare team to help ensure patients receive the testing, treatments, follow-up care and medications they need. We applaud the innumerable selfless acts by healthcare professionals across the nation who are putting themselves in harm’s way to provide care to America’s patients.

    We are issuing this joint statement to highlight the important role that physicians, pharmacists and health systems play in being just stewards of healthcare resources during times of emergency and national disaster. We are aware that some physicians and others are prophylactically prescribing medications currently identified as potential treatments for COVID-19 (e.g.,chloroquine or hydroxychloroquine, azithromycin) for themselves, their families, or their colleagues; and that some pharmacies and hospitals have been purchasing excessive amounts of these medications in anticipation of potentially using them forCOVID-19 prevention and treatment. We strongly oppose these actions.

    Read the full statement.

  • 03/25/2020 4:28 PM | Anonymous member (Administrator)

    In light of the rapidly evolving COVID-19 pandemic and the expected shortage of alcohol-based hand sanitizers, the USP Compounding Expert Committee has offered a resource on Compounding Alcohol-Based Hand Sanitizer During COVID-19 Pandemic.

    On March 24, 2020, recommendations were added by the USP Compounding Expert Committee to respond to stakeholder questions about substitutions in light of shortages of ingredients for compounding alcohol-based hand sanitizers. Formulation 3 was revised due to inherent variability in the raw materials and volatility to ensure that the isopropyl alcohol concentration exceeds the recommendations by the Centers for Disease Control (CDC)

    Additional Information:

    Any additional questions should be directed to the USP Healthcare Quality and Safety staff at CompoundingSL@usp.org.

  • 03/17/2020 2:12 PM | Anonymous member (Administrator)

    The Kansas Department of Commerce is working closely with the Kansas Department of Emergency Management (KDEM) to complete the required steps for requesting an Small Business Administration Economic Injury Disaster Loan Declaration.

    As part of this process, KDEM needs to obtain information from small businesses that have suffered substantial economic injury as a result of the COVID-19 disaster.

    Read more.
  • 03/17/2020 1:34 PM | Anonymous member (Administrator)

    Background: Pharmacies are essential to the health of Kansas residents, as timely and accurate medication delivery is foundational to the treatment of acute and chronic diseases. To best provide care to patients, we must maintain the health of pharmacy staff so that pharmacies can continue operations. Please review this information and consider adopting these strategies in your pharmacies.

    As patients look to pharmacy staff for guidance, please use calming and reassuring language. Your help to prevent panic and communicate accurate information is essential for our communities. Watch the CDC, Department of Health, and your County Public Health Page for accurate information, and resources.

    Prevention: Pharmacies should implement strategies to prevent person to person transmission of infection. Frequent, effective hand washing, use of hand sanitizer and wiping frequently touched surfaces with an EPA approved biocide should be standard practice. Staff should strive to maintain a distance greater than 3 feet from patients, and greater than 6 feet for patients who are actively coughing. Staff should communicate the importance of ill patients staying home, sending a friend to the pharmacy instead, or using the drive-through when possible.

    Exposure: If a patient sick with COVID-19 visited a pharmacy and talked with pharmacy staff, the exposure risk, as classified by the CDC, is generally considered low risk. With low-risk exposures, individuals should perform self-monitoring with delegated supervision until 14 days after the last potential exposure. Asymptomatic individuals in this category are not restricted from work. They should check their temperature twice daily and remain alert for respiratory symptoms consistent with COVID-19 (e.g., cough, shortness of breath, sore throat). They should ensure they do not have a fever and are asymptomatic before leaving home and reporting for work. If they do not have a fever or respiratory symptoms, they may report to work. If they develop fever (measured temperature > 100.0 oF or subjective fever) OR respiratory symptoms they should immediately self-isolate (separate themselves from others) and notify their local or state public health authority or healthcare facility promptly so that they can coordinate consultation and referral to a healthcare provider for further evaluation.

    Planning: Pharmacies should begin to develop emergency plans based on the potential for absenteeism due to illness in their staff. This is an evolving situation that may eventually be worsened by drug shortages. We will continue to share information between state and local public health staff and our pharmacy community as it becomes available.

  • 03/17/2020 10:20 AM | Anonymous member (Administrator)

    The Kansas Pharmacy Foundation is seeking donations for the Silent Auction, which will take place during the Trade Show on Friday, Sept. 25. Items also are needed for the raffle, which will take place throughout the day on Saturday, Sept. 26. Winners will be drawn and announced on Sunday, Sept. 27.

    If you are a season ticket holder to football, basketball, baseball, theater or other events, and you know you won't be able to attend on a certain date, please consider donating the tickets for that particular day.

    Other ideas for donations include:

    • Pharmacy Gear
    • Wine Sets
    • Spirits Sets
    • Gift baskets
    • KC Chiefs Tickets
    • KC Royals Tickets
    • Concert Tickets
    • Trip/Vacation Packages
    • Signed Sports Memorabilia
    • Group Outings/Fan Experiences
    • Smart TV
    • Apple Watch
    • Garmin
    • Bluetooth Speakers
    • KU Jayhawk Gift Basket
    • KSU Wildcat Gift Basket
    • KC Chiefs  Memorabilia
    • KC Royals Memorabilia
    • Luggage
    • Golf Gear
    • Family Items (ride-on toys, backyard games, etc.)
    • Jewelry

    For more information, or to sign-up to donate an item, please contact jen@ksrx.org.

  • 03/16/2020 9:26 AM | Anonymous member (Administrator)

    The American Society of Health-System Pharmacists (ASHP) has made several valuable resources available related to COVID-19. They have opened up to non-members many evidence-based resources and tools relevant to the pandemic, which are now accessible to all healthcare professionals who need them.

    ASHP has unlocked many member resources on ASHP.org including section and topical Resource Centers (e.g., Emergency Preparedness, Geriatrics, Inpatient Care), relevant webinars and online programs (e.g., infectious diseases, flu, disaster and mass casualty preparedness, and well-being and resilience), and select AJHP articles. Additionally, public access to AHFS Drug Information is available for the next 60 days with the username "ahfs@ashp.org" and password "covid-19."

    We want to thank ASHP for making these resources available and hope that you will share this information with your professional networks so that pharmacists, student pharmacists, pharmacy technicians, and other healthcare professionals can access these tools and resources.

  • 03/15/2020 8:56 PM | Anonymous member (Administrator)

    The Kansas Pharmacists Association strongly recommends that all pharmacies take the following actions:

    1. Use calming and reassuring language when patients ask for information.
    2. Have a fact sheet available to answer questions from patients on prescription refills, emergency supplies, payer coverage of medications, and other Rx-related information.
    3. Encourage patients to have appropriate medications on hand to treat viral symptoms, so they will not have to go out if they develop COVID-19.
    4. Establish a process for older adults, pregnant women, and individuals with chronic health conditions to obtain medications without waiting in line, such as utilizing pharmacy drive-through window option or medication delivery service if available.
    5. Report unusual patient complaints, surges in symptoms of fever, cough, or respiratory distress, or surges in sales volumes of cold and flu medications, over-the-counter painkillers, or hand sanitizer.
    6. Implement infection control procedures, especially for clinic waiting areas:
      • Provide a mask to customers who are coughing or sneezing.
      • Make sure staff maintain a distance of 3 feet from asymptomatic patients and at least 6 feet from those actively coughing.
      • Regularly clean and disinfect counters, waiting areas, and other spaces where public interaction occurs with an EPA-approved disinfectant. Clean at least every hour or after every 10 patients, whichever is more frequent.
      • Place alcohol-based hand sanitizer next to the checkout window so people can sanitize their hands after using common items, like the pen used to sign for prescriptions.
    7. Monitor all staff for sickness regularly. Take temperatures once per shift and send them home if they have symptoms of a respiratory infection.
    8. Update sick leave policies to place employees on sick leave if a family member is sick and to develop a post-illness return-to-work procedure.
    9. Take recommended actions for unprotected exposures (e.g., not using recommended personal protective equipment, an unrecognized infectious patient contact).
    10. Know your active standing orders, collaborative practice agreements, and memorandums of understanding. Know the most up to date timelines on when you may be receiving certain capabilities or products (vaccines, therapeutics, testing).

KPhA appreciates the generous support provided by

Diamond Corporate Members
Silver Corporate Members
Bronze Corporate Members
Compliant Pharmacy Alliance
PBA Health
Pharmacists Mutual

Kansas Pharmacists

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software